{"id":55305,"date":"2014-01-22T18:18:00","date_gmt":"2014-01-22T22:18:00","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=55305"},"modified":"2022-07-28T14:32:37","modified_gmt":"2022-07-28T19:32:37","slug":"new-business-now-open-national-drug-screening-inc","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/new-business-now-open-national-drug-screening-inc\/","title":{"rendered":"New Business Now Open &#8211; National Drug Screening, Inc"},"content":{"rendered":"\n<p><strong>National Drug Screening<\/strong>, Inc. (NDS) will fulfill an industry need for a state of the art technology software platform combined with <strong><a href=\"https:\/\/www.nationaldrugscreening.com\/mro-service\/\">Medical Review Officer (MRO) services<\/a><\/strong>, drug testing, training and consultation. Services will be offered to small and medium-size Third Party Administrator (TPA) operations. NDS will offer one system for scheduling, ordering and processing <strong>paperless drug testing<\/strong> using all major SAMHSA laboratories. Clients will save time and money with an efficient electronic process for ordering tests and receiving test results. Point of collection testing programs will provide for the negative drug test result to be electronically delivered to the client within minutes.<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>National Drug Screening, Inc. (NDS) will fulfill an industry need for a state of the art technology software platform combined with Medical Review Officer (MRO) services, drug testing, training and consultation. Services will be offered to small and medium-size Third Party Administrator (TPA) operations. NDS will offer one system for scheduling, ordering and processing paperless [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":1124,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51361,51029,51514,51000,51551,51573","_relevanssi_noindex_reason":"","footnotes":""},"categories":[132,76],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55305"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=55305"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55305\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/1124"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=55305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=55305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=55305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}